Astria Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Market Capitalization	524	279	251	70	43	70	31	34	67	121	-
Market Cap Growth	-	11.26%	257.29%	63.15%	-38.35%	124.59%	-9.74%	-48.92%	-44.49%	-	-
Enterprise Value	278	33	25	-55	-1	36	-7	20	34	67	-10
PE Ratio	-3.82	-3.82	-4.83	-0.32	-1.15	-2.65	-1.20	-1.26	-1.87	-3.72	-
PS Ratio	-	-	-	-	-	-	-	68.79	-	-	-
PB Ratio	2.16	1.15	1.13	0.57	1.06	1.95	0.89	2.92	2.32	2.40	-
P/FCF Ratio	-4.07	-4.07	-5.74	-2.32	-1.32	-2.62	-1.34	-1.28	-2.02	-4.02	-
P/OCF Ratio	-4.07	-4.07	-5.76	-2.33	-1.32	-2.62	-1.32	-1.28	-2.05	-4.07	-
EV/Sales Ratio	-	-	-	-	-	-	-	40.78	-	-	-
EV/EBITDA Ratio	-0.45	-0.45	-0.48	0.28	0.02	-1.36	0.25	-0.77	-0.99	-2.14	0.47
EV/EBIT Ratio	-0.45	-0.45	-0.48	0.28	0.02	-1.36	0.25	-0.76	-0.98	-2.13	0.46
EV/FCF Ratio	-0.48	-0.48	-0.57	1.82	0.03	-1.34	0.28	-0.76	-1.03	-2.23	0.49
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.03	0.06	-	0.21	0.20	0.18	-0.06
Debt / EBITDA Ratio	0.00	0.00	-0.02	0.00	-0.03	-0.09	-	-0.09	-0.16	-0.28	-0.22
Debt / FCF Ratio	0.00	0.00	-0.02	-0.01	-0.03	-0.08	-	-0.09	-0.17	-0.29	-0.23
Quick Ratio	21.34	21.34	24.99	24.12	7.03	7.20	9.01	2.74	4.64	8.08	3.49
Current Ratio	21.73	21.73	25.13	24.42	7.25	7.74	9.33	2.90	4.75	8.17	3.55
Asset Turnover	0	0	0	0	0	0	0	0.02	0	0	0
Interest Coverage	-	-	-	-	-	-	-257.70	-58.23	-42.08	-32.36	-105.23
Return on Equity (ROE)	-34.70%	-34.70%	-38.20%	-304.10%	-76.70%	-62.90%	-77.10%	-150.00%	-102.70%	-132.60%	34.90%
Return on Assets (ROA)	-33.40%	-33.40%	-36.30%	-158.90%	-67.60%	-55.80%	-67.60%	-103.80%	-76.70%	-52.80%	-93.20%
Return on Capital (ROIC)	-34.11%	-34.11%	-24.08%	-158.94%	-89.74%	-71.33%	-75.47%	-189.85%	-102.15%	-53.31%	31.74%
Earnings Yield	-13.90%	-26.15%	-20.69%	-312.81%	-86.78%	-37.71%	-83.33%	-79.56%	-53.55%	-26.90%	-
FCF Yield	-13.06%	-24.56%	-17.41%	-43.03%	-75.66%	-38.12%	-74.40%	-78.10%	-49.40%	-24.91%	-
Buyback Yield / Dilution	-106.03%	-106.03%	-63.81%	-191.81%	-63.87%	-121.55%	-133.14%	-33.59%	-101.82%	-1794.46%	-12.00%
Total Shareholder Return	-106.03%	-106.03%	-63.81%	-191.81%	-63.87%	-121.55%	-133.14%	-33.59%	-101.82%	-1794.46%	-12.00%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).